Tag: GLP-1

Apr 27, 2026

• pharmacogenomics
• GLP-1
• precision-medicine
• weight-loss
• tirzepatide
• semaglutide

Apr 27, 2026

• GLP-1
• sarcopenia
• muscle-preservation
• body-composition
• lean-mass
• prevention

Apr 26, 2026

• substance
• GLP-1
• amylin
• incretin
• obesity
• type-2-diabetes
• body-composition
• wearable-confounder
• investigational

Apr 26, 2026

• substance
• GLP-1
• incretin
• obesity
• metabolic-health
• type-2-diabetes
• body-composition
• wearable-confounder
• FDA-approved

Apr 26, 2026

• mechanism
• GLP-1
• amylin
• incretin
• obesity
• satiety

Apr 26, 2026

• GLP-1
• semaglutide
• Ozempic
• Wegovy
• liraglutide
• FDA
• warning-letter
• pharmacovigilance
• adverse-event-reporting
• medication-safety
• coaching-guidance

Apr 25, 2026

• obesity
• GLP-1
• myostatin
• activin
• lean-mass
• phase-2
• investigational
• frontier
• body-composition

Apr 25, 2026

• substance
• obesity
• GLP-1
• body-composition
• lean-mass
• myostatin
• activin
• phase-2
• investigational

Apr 25, 2026

• GLP-1
• safety
• pancreatitis
• adverse-event
• semaglutide
• tirzepatide
• pharmacovigilance

Apr 25, 2026

• GLP-1
• semaglutide
• NAION
• safety
• ophthalmology
• optic-nerve
• adverse-event
• pharmacovigilance
• Vitals

Apr 24, 2026

• transcription-factor
• muscle
• GLP-1
• preclinical
• oncogene
• frontier

Apr 24, 2026

• glp-1
• adverse-events
• muscle-atrophy
• sarcopenia
• osteoporosis
• bone-density
• faers
• safety-signal
• GLP-1

Apr 23, 2026

• pharmacogenomics
• GLP-1
• precision-medicine
• non-response
• tirzepatide
• semaglutide
• liraglutide

Apr 21, 2026

• GLP-1
• safety
• ophthalmology
• NAION
• semaglutide
• tirzepatide
• adverse-event
• optic-nerve

Apr 21, 2026

• GLP-1
• fat-free-mass
• muscle
• systematic-review
• ACP-2026
• evidence-gap

Apr 20, 2026

• obesity
• GLP-1
• myostatin
• activin
• lean-mass
• phase-2
• investigational
• frontier

Apr 20, 2026

• protocol
• GLP-1
• body-composition
• protein
• recovery
• Ben-specific

Apr 20, 2026

• hub
• peptide-protocol
• GLP-1
• body-composition
• protein
• lean-mass
• retatrutide
• Ben-specific

Apr 20, 2026

• protocol
• peptide-protocol
• retatrutide
• body-composition
• lean-mass
• GLP-1
• GCGR
• Vitals

Apr 05, 2026

• sarcopenia
• coaching
• protocol
• tier
• Green-Yellow-Red
• GLP-1
• muscle-health

Apr 05, 2026

• GLP-1
• body-composition
• lean-mass
• sarcopenia
• muscle-loss
• safety